Skip to main
VBLT
VBLT logo

Vascular Biogenics (VBLT) Earnings Dates & Reports

Vascular Biogenics (VBLT) Most Recent Earnings

Report Date
Period EndingQ4 2022
Est. EPS-$0.14
Actual EPS-$0.05
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Vascular Biogenics (VBLT) Earnings per Share (EPS) History

Signup for full access
Browse free

Vascular Biogenics (VBLT) Latest Earnings

The value each VBLT share was expected to gain vs. the value each share gained.

Vascular Biogenics (VBLT) reported its most recent earnings on for Q4 2022, posting earnings per share (EPS) of -$0.05. This exceeded analysts' expectations of -$0.14 by 64.29%, marking a Beat.

For comparison, Vascular Biogenics reported EPS of -$0.12 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

Vascular Biogenics (VBLT) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2023
-$0.01
DeckReportListen
Q1 2023
-$0.03
DeckReportListen
Q4 2022
-$0.14-$0.05-64.29%
DeckReportListen
Q3 2022
-$0.11-$0.12+9.09%
DeckReportListen
Q2 2022
-$0.13-$0.12-7.69%
DeckReportListen
View all

Vascular Biogenics (VBLT) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Vascular Biogenics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Vascular Biogenics (VBLT) Earnings FAQs

Vascular Biogenics (VBLT) last reported earnings on Mar 14, 2023 for Q4 2022, posting an EPS of -$0.05, which Beat the estimate of -$0.14 by 64.29%.

For Q4 2022, Vascular Biogenics (VBLT) reported an EPS of -$0.05, exceeding analysts' estimate of -$0.14 by 64.29%.

For Q4 2022, Vascular Biogenics (VBLT) Beat expectations with an actual EPS of -$0.05 vs. an estimated EPS of -$0.14.

Following the last earnings report on Mar 14, 2023, Vascular Biogenics (VBLT)'s stock price moved — from — to —.

The next Vascular Biogenics (VBLT) earnings call is scheduled for Aug. 14, 2023, where executives will discuss financial results and outlook.

Vascular Biogenics (VBLT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.